Malignant neoplasm of lymphoid, hematopoietic and/or related tissue clinical trials in North Carolina
7 active Malignant neoplasm of lymphoid, hematopoietic and/or related tissue trials with a site in North Carolina. Describe your situation to see which ones look like a fit.
- Effectiveness of Central Oncology Navigation and the Use of an ORN
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
- ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
- Implementation of an Oral Chemotherapy Adherence Intervention
- Long-Term Follow-up Study
- Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
← All Malignant neoplasm of lymphoid, hematopoietic and/or related tissue trials